Khondrion, a Nijmegen, the Netherlands-based clinical-stage biopharmaceutical firm growing therapies for main mitochondrial illness (PMD), obtained an Innovation Credit score…
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
You can revoke your consent any time using the Revoke consent button.